Competitive intelligence on 
 small-molecule drugs and 
 the 90,000 global patents 
 covering them 

Start your free trial now

DrugPatentWatch Archives

You are currently viewing the 2009 archives
Click here to return to the current data set

DrugPatentWatch Ultimate Plan Preview

Profile for Tradename: SYNTHROID

« Back to Dashboard

Synthroid is a drug marketed by Abbvie and is included in one NDA. It is available from nine suppliers.

The generic ingredient in SYNTHROID is levothyroxine sodium. There are five drug master file entries for this compound. Twenty-eight suppliers are listed for this compound. Additional details are available on the levothyroxine sodium profile page.

Summary for Tradename: SYNTHROID

Patents:0
Applicants:1
NDAs:1
Suppliers: see list9
2013 Sales:$858,725,000

Pharmacology for Tradename: SYNTHROID

Ingredient-typeThyroxine
Drug Classl-Thyroxine

Clinical Trials for: SYNTHROID

Combined Levothyroxine/Liothyronine Supplementation in Hypothyroid Patients With Brain Tumors
Status: Terminated Condition: Hypothyroidism; Brain Tumor

Evaluation of the Efficacy and Safety of Levothyroxine in Brain Death Organ Donors: a Randomized Controled Trial
Status: Recruiting Condition: Brain Dead Organ Donors

Desiccated Thyroid Extract and Levothyroxine for Hypothyroidism Treatment
Status: Recruiting Condition: Primary Hypothyroidism.

Thyroid Hormone Dose Adjustment in Pregnancy
Status: Recruiting Condition: Pregnancy; Hypothyroidism

Effects of L-thyroxine Replacement on Serum Lipid and Atherosclerosis in Hypothyroidism
Status: Active, not recruiting Condition: Hypothyroidism; Thyroid Diseases; Endocrine System Diseases

Levothyroxine for Children With Euthyroid Sick Syndrome
Status: Completed Condition: Euthyroid Sick Syndrome

Bioequivalence of Two Levothyroxine Tablet Formulations in Healthy Indian Volunteers
Status: Completed Condition: Hypothyroidism

Thyroid Lobectomy With or Without Levothyroxine Treatment Postoperatively
Status: Completed Condition: Recurrent Goiter

Study of Optimal Replacement of Thyroxine in the Elderly
Status: Recruiting Condition: Hypothyroidism

Thyroxin Treatment in Sub Clinical Hypothyroidism, on the Apnea Hypopnea Index Score, Lipids and Highly Sensitive CRP
Status: Recruiting Condition: Dyslipidemia

Courtesy of ClinicalTrials.org
See more clinical trials for this drug
Glossary
Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Abbott
SYNTHROID
levothyroxine sodium
TABLET; ORAL021402Jul 24, 2002RXNo<disabled><disabled>
Abbott
SYNTHROID
levothyroxine sodium
TABLET; ORAL021402Jul 24, 2002RXYes<disabled><disabled>
This preview shows a limited data set
Subscribe for full access, or try a free trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a free trial or see the plan comparison

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.

Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided information. There is no warranty that the information contained herein is error free. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Connect with Social Media:

Follow DrugPatentWatch on Twitter Connect with DrugPatentWatch on Linkedin Drug Patents on LinkedIn

Copyright © 2002-2014 thinkBiotech LLC. ISSN: 2162-2639

Other thinkBiotech sites: PatentStatBiotechBlogJournal of Commercial Biotechnology

`abc